(Q44338875)

English

Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Hong Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Pramila Kumari

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mark Laughlin

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mary Jane Hilbert

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Stephen R Indelicato

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Josephine Lim

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chin-Chung Lin

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Amin A Nomeir

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Journal of Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

987

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

243-248

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

High-performance liquid chromatographic analysis of the anti-fungal agent SCH 56592 in dog serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

Problems in management of opportunistic fungal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901599-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9673(02)01599-6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44338875&oldid=2109559410"